OncoMethylome Changing Business Model to Focus on Clinical Dx | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – In the midst of reporting its first half earnings, Belgian molecular diagnostics firm OncoMethylome Sciences today said it is changing its business model to concentrate on its commercial clinical diagnostic operations while moving away from basic research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.